Please login to the form below

Not currently logged in

Smart Thinking blog

Insights and expert advice on the key issues facing today’s pharma marketer

Oxford PharmaGenesis named in Medical Marketing and Media’s Agency 100 report

Media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in the latest Agency 100 – the annual definitive ‘who’s who’ ranking of the sector’s top healthcare marketing firms in North America.

The 2021 ranking is based on information about healthcare communications companies’ 2020 results, including financial results. Eagerly anticipated in the sector, it’s an important gauge of the sector’s health, and maps out the key players in a competitive and fast-evolving field.

Meeting the exacting criteria set by MM+M, Oxford PharmaGenesis was able to demonstrate very strong growth from our work with both long-term and new clients, and our projected growth over 2021. Our submission detailed our wide range of professional specialties and the expertise held by our colleagues, along with striking creative samples showcasing the breadth and variety of our work, our deep understanding of client needs and our innovative approach.

Credit for the leading independent company’s inclusion in this year’s Agency 100 goes, in particular, to colleagues in our US office, based in Philadelphia.

Oxford PharmaGenesis CEO Chris Winchester said: “This is a hugely important award for agencies in our sector in North America. We’re very proud to be recognised for the quality of our work with clients, and the ongoing success of the company.

“Congratulations in particular to the team in our Philadelphia office for their commitment to the Oxford PharmaGenesis standards of quality and service. This ranking is truly well earned.”

Speaking from the Oxford PharmaGenesis US office, Executive Vice President Brian Falcone said: “I am thrilled that the hard work of our colleagues across the world has allowed us to secure this designation. We have some remarkable people here at Oxford PharmaGenesis and their contributions absolutely deserve recognition.”

Find out more here.

From Oxford PharmaGenesis

1st July 2021

From: Marketing


COVID-19 Updates and Daily News

Featured jobs


Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Securing a future for telehealth with immersive market research insights...